Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 97,628 |
|
|||||
| News | - | ||||||
| Day High | 1.2603 | Low High |
|||||
| Day Low | 1.2101 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cardiff Oncology Inc | CRDF | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0093 | -0.76% | 1.2207 | 18:49:26 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.22 | 1.2101 | 1.2603 | 1.26 | 1.23 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 629 | 97,628 | US$ 1.25 | US$ 121,632 | - | 0.94 - 2.79 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:49:26 | formt | 200 | US$ 1.2207 | USD |
Cardiff Oncology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 53.17M | 44.68M | - | 386k | -38.73M | -0.87 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cardiff Oncology News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/20/2023 | 15:05 | PR Newswire (US) | Cardiff Oncology to Present at the 35th Annual Piper Sandler.. |
| 11/02/2023 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/02/2023 | 15:05 | PR Newswire (US) | Cardiff Oncology Reports Third Quarter 2023 Results and.. |
| 11/02/2023 | 15:02 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/26/2023 | 15:05 | PR Newswire (US) | Cardiff Oncology to Report Third Quarter 2023 Financial.. |
| 9/26/2023 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/26/2023 | 15:05 | PR Newswire (US) | Cardiff Oncology Announces Positive Clinical Data in.. |
| 9/05/2023 | 07:00 | PR Newswire (US) | Cardiff Oncology to Present at Upcoming Investor Conferences.. |
| 8/09/2023 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/09/2023 | 15:05 | PR Newswire (US) | Cardiff Oncology Reports Second Quarter 2023 Results and.. |
| 8/09/2023 | 15:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 8/07/2023 | 15:42 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRDF Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.20 | 1.28 | 1.15 | 1.21 | 128,101 | 0.0207 | 1.73% |
| 1 Month | 1.20 | 1.28 | 0.94 | 1.12 | 192,127 | 0.0207 | 1.73% |
| 3 Months | 1.76 | 2.0193 | 0.94 | 1.47 | 740,403 | -0.5393 | -30.64% |
| 6 Months | 1.61 | 2.79 | 0.94 | 1.72 | 639,510 | -0.3893 | -24.18% |
| 1 Year | 1.60 | 2.79 | 0.94 | 1.70 | 427,947 | -0.3793 | -23.71% |
| 3 Years | 25.01 | 25.50 | 0.94 | 6.28 | 770,952 | -23.79 | -95.12% |
| 5 Years | 0.73 | 25.50 | 0.4227 | 5.89 | 835,902 | 0.4907 | 67.22% |
Cardiff Oncology Description
| Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias. |
